RNA FY 2020 Earnings — Avidity Biosciences, Inc. Revenue & Financial Results | Market Cap Arena

RNAAvidity Biosciences, Inc.

$2B

FY 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$7M+192.7% YoY

Gross Profit

-$31M-454.0% margin

Operating Income

-$44M-652.4% margin

Net Income

-$44M-653.5% margin

EPS (Diluted)

$-2.05

Cash Flow

Operating Cash Flow

-$37M

Free Cash Flow

-$38M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$334M

Total Liabilities

$28M

Stockholders' Equity

$306M

Cash & Equivalents

$321M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$7M	$2M	+192.7%
Gross Profit	-$31M	$2M	-1428.8%
Operating Income	-$44M	-$17M	-155.5%
Net Income	-$44M	-$25M	-79.3%